Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for scar prevention after breast augmentation
TCTR20200117002Enrolling by invitation
- Sponsor
- Thammasat University
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in surgical scar (2 arms), sponsored by Thammasat University. Primary endpoint: Primary scar outcome. Started Jan 2020; status: enrolling by invitation.
02
Drugs
botulinum toxin type A
03
Conditions
surgical scar
Beyond the preview
Go deeper on TCTR20200117002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200117002.